These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30255471)

  • 21. Complexation and solubility behavior of albendazole with some cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM
    Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers.
    Nie S; Zhang S; Pan W; Liu Y
    Drug Dev Ind Pharm; 2011 May; 37(5):606-12. PubMed ID: 21469949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
    Godugu C; Doddapaneni R; Singh M
    Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
    Liu J; Chen X; Ward T; Pegram M; Shen K
    Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Succinyl-β-cyclodextrin: Influence of the substitution degree on albendazole inclusion complexes probed by NMR.
    Priotti J; García A; Leonardi D; Ferreira MJ; Lamas MC; Nunes TG
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():694-702. PubMed ID: 30184797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
    Takai K; Le A; Weaver VM; Werb Z
    Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclodextrin-based nanosponges: effective nanocarrier for tamoxifen delivery.
    Torne S; Darandale S; Vavia P; Trotta F; Cavalli R
    Pharm Dev Technol; 2013; 18(3):619-25. PubMed ID: 22235935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the solubility characteristics of albendazole with dimethyl-beta-cyclodextrin.
    Kata M; Schauer M
    Acta Pharm Hung; 1991 Jan; 61(1):23-31. PubMed ID: 1872189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
    Wu J; Shen Q; Fang L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha- and Beta-Cyclodextrin Inclusion Complexes with 5-Fluorouracil: Characterization and Cytotoxic Activity Evaluation.
    Di Donato C; Lavorgna M; Fattorusso R; Isernia C; Isidori M; Malgieri G; Piscitelli C; Russo C; Russo L; Iacovino R
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27916966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin.
    Dhanaraju MD; Kumaran KS; Baskaran T; Moorthy MS
    Drug Dev Ind Pharm; 1998 Jun; 24(6):583-7. PubMed ID: 9876628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel water-soluble fisetin/cyclodextrins inclusion complexes: Preparation, characterization, molecular docking and bioavailability.
    Zhang JQ; Jiang KM; An K; Ren SH; Xie XG; Jin Y; Lin J
    Carbohydr Res; 2015 Dec; 418():20-28. PubMed ID: 26531135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
    Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
    Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies.
    Mendes C; Buttchevitz A; Kruger JH; Kratz JM; Simões CM; de Oliveira Benedet P; Oliveira PR; Silva MA
    Eur J Pharm Sci; 2016 Feb; 83():71-8. PubMed ID: 26687444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
    Palma G; Conte C; Barbieri A; Bimonte S; Luciano A; Rea D; Ungaro F; Tirino P; Quaglia F; Arra C
    Int J Pharm; 2014 Oct; 473(1-2):55-63. PubMed ID: 24992317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer.
    Rahman S; Cao S; Steadman KJ; Wei M; Parekh HS
    Drug Deliv; 2012; 19(7):346-53. PubMed ID: 23030405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
    Rao MRP; Chaudhari J; Trotta F; Caldera F
    AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
    Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
    Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repositioning of amprenavir as a novel extracellular signal-regulated kinase-2 inhibitor and apoptosis inducer in MCF-7 human breast cancer.
    Jiang W; Li X; Li T; Wang H; Shi W; Qi P; Li C; Chen J; Bao J; Huang G; Wang Y
    Int J Oncol; 2017 Mar; 50(3):823-834. PubMed ID: 28197631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.